Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients’ Evidence From Latin America

Humberto Martinez-Cordero Honoraria: Janssen, Sanofi, Bristol Myers Squibb/Celgene, Takeda Consulting orAdvisoryRole: Janssen, Sanofi,Bristol MyersSquibb/Celgene, Takeda Travel, Accommodations, Expenses: Sanofi Camila Peña Honoraria: Janssen Consulting or Advisory Role: Janssen Travel, Accommodation...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoir:	Martínez-Cordero, Humberto (author)
Rannpháirtithe:	Peña, Camila (author), Schutz, Natalia Paola (author), Bove, Virginia (author), Villano, Fiorella (author), Beltrán, Cecilia (author), Donoso, Javiera (author), López-Vidal, Hernán (author), Roa Salinas, Macarena Alejandra (author), Soto, Pablo (author), Ochoa, Paola (author), Duarte, Patricio (author), Riva, Eloísa (author)
Formáid:	article
Teanga:	Béarla
Foilsithe / Cruthaithe:	2023
Ábhair:	PERSONA DE MEDIANA EDAD PROTOCOLOS DE QUIMIOTERAPIA COMBINADA ANTINEOPLÁSICA BORTEZOMIB CICLOFOSFAMIDA DEXAMETASONA MIELOMA MÚLTIPLE PRONÓSTICO TALIDOMIDA RESULTADO DEL TRATAMIENTO USOS TERAPÉUTICOS QUIMIOTERAPIA EPIDEMIOLOGÍA
Rochtain ar líne:	https://hdl.handle.net/20.500.12008/53300
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!